Home › BIO Issues Statement on Hepatitis C medicines report.
 

Keywords :   


BIO Issues Statement on Hepatitis C medicines report.

2015-12-07 14:31:08| Industrial Newsroom - All News for Today

In his statement regarding report released by Senators Grassley and Wyden, BIO Senior VP of Communications Kenneth Lisaius stated that BIO is reviewing said report in full and generally does not comment on product pricing by member companies. Lisaius added, however, that "balanced debate about the cost of groundbreaking cures" cannot narrow their focus on price but also acknowledge value provided to patients as well as overall healthcare system.

Tags: report issues statement bio

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »